Remy Robert

Remy Robert is an Associate Professor in Physiology at Monash University, affiliated with the Monash Biomedicine Discovery Institute. His primary role is in the Department of Molecular Biology and Biochemistry, focusing on therapeutic antibody development and antibody engineering. He holds a PhD from the University of Bordeaux and completed a postdoctoral fellowship at CSIRO, followed by a research fellowship at Monash University under Professor Charles Mackay.

Dr. Robert’s research spans translational medicine, aiming to convert academic discoveries into antibody therapies. His expertise includes protein engineering, autoimmune disease mechanisms, and inflammation modulation. Key projects include the development of bispecific antibodies for cancer immunotherapy, chemokine-targeted therapeutics, and preclinical studies on CCR6-mediated autoimmune diseases.

His research outputs emphasize antibody engineering techniques, mouse models of atopic dermatitis, and the role of receptors like GPR109A and CXCR1 in immune regulation. Collaborations involve institutions like CSIRO and global networks in immunology. He leads grants on cancer immunotherapy and has contributed to patents related to antibody technologies.

Dr. Robert’s work aligns with UN Sustainable Development Goals focused on good health and well-being. His lab actively pursues innovations in therapeutic antibodies, with a focus on translational applications in oncology and autoimmune diseases.